Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-92Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-31Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report
/in Dendritic Cells, Glioblastoma, International Publications /von 2000-12-15 / Neurosurg Focus 2000 Dec;9(6):e8Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
/in Breast Cancer, Dendritic Cells, International Publications, Ovarian Cancer /von 2000-11-01 / Blood 2000 Nov;96(9):3102-8Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-16Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-15Clinical applications of dendritic cell vaccines
/in Dendritic Cells, International Publications /von 2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-8Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 1999-12-01 / Br. J. Haematol. 1999 Dec;107(3):648-55Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
/in Colorectal Cancer, Dendritic Cells, International Publications /von 1999-07-02 / Int. J. Cancer 1999 Jul;82(1):121-4
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
- Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
- Immunotherapy in breast cancer: an overview of current strategies and perspectives